PerkinElmer Aktie
113,74USD | 1,55USD | 1,38% |
WKN: 850943 / ISIN: US7140461093
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 99,62 |
T. Rowe Price Investment Management, Inc. | 14,62 |
T. Rowe Price Investment Management, Inc. | 14,62 |
The Vanguard Group, Inc. | 11,65 |
Vanguard Group, Inc. (Subfiler) | 11,17 |
T Rowe Price Capital Appreciation Fund | 9,47 |
T. Rowe Price Associates, Inc. (IM) | 5,32 |
Janus Henderson Investors US LLC | 5,21 |
T Rowe Price Associates, Inc. (13F Subfiler) | 5,18 |
Janus Henderson Investors US LLC | 4,91 |
State Street Corp. | 4,26 |
Select Equity Group LP | 4,25 |
Select Equity Group LP | 4,25 |
Janus Henderson Enterprise Fund | 3,68 |
Vanguard Total Stock Market ETF | 3,20 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 13 000 | 14 000 | 16 700 | 16 700 | 11 500 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,22 | 0,27 | 0,30 | 0,20 | 0,24 |
Bilanz (in Mio. USD) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 1 374 | 2 239 | 2 441 | 3 289 | 3 001 |
Summe Anlagevermögen | 5 164 | 5 721 | 12 560 | 10 841 | 10 564 |
Summe Aktiva | 6 539 | 7 960 | 15 001 | 14 130 | 13 565 |
Bilanz (in Mio. USD) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Fremdkapital | 3 725 | 4 225 | 7 859 | 6 747 | 5 692 |
Summe Eigenkapital | 2 814 | 3 735 | 7 141 | 7 383 | 7 873 |
Summe Passiva | 6 539 | 7 960 | 15 001 | 14 130 | 13 565 |
Adresse
77 Citypoint 4th Avenue, 02451 Waltham | |
Telefon | +1 (877) 373-6374 |
Internet | http://www.revvity.com |
Management
Alexis Platon Michas
Non-Executive Chairman |
Anita Gonzales
Vice President & Controller |
Arvind Sundar Rajan
Vice President-Digital & Technology |
Bryan A. Kipp
VP & General Manager-Life Sciences Integration |
Daniel R. Tereau
Senior VP-Strategy & Business Development |
Franklin R. Witney
Independent Director |
Jayashree Kailas Thacker
Chief Information Officer & Senior Vice President |
Joel S. Goldberg
Secretary, SVP-Administration & General Counsel |
Madhuri Hegde
Chief Scientific Officer & Senior Vice President |
Magali Four
Chief People & Culture Officer & SVP |
Maxwell Krakowiak
Chief Financial Officer & Senior Vice President |
Michael Klobuchar
Independent Director |
Michel Pericles Vounatsos
Independent Director |
Michelle McMurry-Heath
Independent Director |
Miriame Victor
Chief Commercial Officer & Senior Vice President |
Pascale Witz
Independent Director |
Peter Barrett
Independent Director |
Prahlad Ramadhar Singh
President, Chief Executive Officer & Director |
Samuel Ross Chapin
Independent Director |
Sophie V. Vandebroek
Independent Director |
Steve Willoughby
Vice President-Investor Relations |
Tajinder S. Vohra
Senior Vice President-Global Operations |
Yi Ping Lin
Chief Quality, Regulatory & Clinical Officer |